DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 97 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,188,000 | +121.0% | 58,619 | +50.4% | 0.34% | +54.3% |
| Q2 2020 | $990,000 | -21.8% | 38,983 | -43.4% | 0.22% | -44.3% |
| Q1 2020 | $1,266,000 | -66.4% | 68,915 | -59.7% | 0.39% | -52.6% |
| Q4 2019 | $3,769,000 | +889.2% | 171,088 | +379.6% | 0.83% | +704.9% |
| Q4 2018 | $381,000 | -47.2% | 35,673 | -24.6% | 0.10% | -3.7% |
| Q3 2018 | $722,000 | +24.7% | 47,286 | 0.0% | 0.11% | +17.6% |
| Q2 2018 | $579,000 | +28.1% | 47,286 | 0.0% | 0.09% | +21.3% |
| Q1 2018 | $452,000 | -22.2% | 47,286 | -26.5% | 0.08% | -27.9% |
| Q4 2017 | $581,000 | – | 64,340 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |